Kidney Transplantation Clinical Trials

A listing of Kidney Transplantation medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 90 clinical trials
Featured trial
BIVV020 in Prevention and Treatment of Antibody-mediated Rejection (AMR)  

transplant participants To characterize the pharmacokinetic (PK) profile of BIVV020 in kidney transplant participants To evaluate the immunogenicity of BIVV020

corticosteroids
ivig
tacrolimus
kidney transplant
  • 16 views
  • 25 Jan, 2023
  • 20 locations
Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients

The purpose of this research is to see if a dose of the Janssen Ad26.CoV2.S vaccine effects the immune protection in individuals who have had a kidney transplant and two or three doses of mRNA

  • 0 views
  • 04 Oct, 2022
  • 3 locations
A Pivotal Phase 3 Trial to Evaluate the Safety and Efficacy of Clazakizumab for the Treatment of Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients (IMAGINE)

This trial investigates the efficacy and safety of clazakizumab [an anti-interleukin (IL)-6 monoclonal antibody (mAb)] for the treatment of CABMR in recipients of a kidney transplant.

  • 142 views
  • 25 Oct, 2022
  • 69 locations
A Controlled, Open-label PA Efficacy and Safety Study in Imlifidase Desensitised Kidney Tx Patients With Positive XM Against a Deceased Donor Prior to Imlifidase Treatment, Including Non-comparative Registry and Concurrent Reference Cohorts (PAES)

(XM) against a deceased donor prior to desensitized with imlifidase and subsequent kidney transplantation. Two non-comparative reference cohorts are included to assess the impact of differences in

  • 0 views
  • 16 Oct, 2022
  • 6 locations
BIVV020 in Prevention and Treatment of Antibody-mediated Rejection (AMR)

transplant participants To characterize the pharmacokinetic (PK) profile of BIVV020 in kidney transplant participants To evaluate the immunogenicity of BIVV020

corticosteroids
ivig
tacrolimus
kidney transplant
  • 0 views
  • 07 Oct, 2022
  • 16 locations
A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IV (CKD)

The aim of this Phase 2 study is to evaluate the safety and efficacy of the live biotherapeutic product, KT-301 (formerly US-APR2020), in the management of patients with CKD Stage IV.

  • 11 views
  • 22 Oct, 2022
  • 5 locations
The Effects of Physical Activity Behavior Change in Kidney Transplant Recipients

, physical activity level, physical activity behavior, physical activity barriers and gait parameters in kidney transplant recipients.

  • 0 views
  • 04 Oct, 2022
  • 1 location
Late Abatacept Conversion in Kidney Transplant Recipients Receiving Belatacept: a Prospective, Randomized Controlled Non-inferiority Trial. IM101-884

This is a single center, randomized, controlled phase 2b, conversion trial. This protocol has been developed to answer the question: Can patients be safely converted from monthly belatacept IV infusions to abatacept subcutaneous injections without a decrease in kidney function.The primary objective will be the difference in estimated GFR (eGFR) …

  • 0 views
  • 27 Oct, 2022
  • 1 location
Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx (ConfIdeS)

An open-label, controlled, randomized Phase 3 trial evaluating 12-month kidney function in highly sensitized (cPRA ≥99.9%) kidney transplant patients with positive crossmatch against a deceased

  • 0 views
  • 04 Oct, 2022
  • 10 locations
  • 47 views
  • 28 Oct, 2022
  • 17 locations